| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |